Search Results

There are 43605 results for: content related to: WHY DO SOME DEPRESSED OUTPATIENTS WHO ARE NOT IN REMISSION ACCORDING TO THE HAMILTON DEPRESSION RATING SCALE NONETHELESS CONSIDER THEMSELVES TO BE IN REMISSION?

  1. THE REMISSION FROM DEPRESSION QUESTIONNAIRE AS AN OUTCOME MEASURE IN THE TREATMENT OF DEPRESSION

    Depression and Anxiety

    Volume 31, Issue 6, June 2014, Pages: 533–538, Mark Zimmerman, Jennifer H. Martinez, Naureen Attiullah, Michael Friedman, Cristina Toba and Daniela A. Boerescu

    Version of Record online : 2 OCT 2013, DOI: 10.1002/da.22178

  2. A systematic review of the clinical relevance of repetitive transcranial magnetic stimulation

    Acta Psychiatrica Scandinavica

    Volume 130, Issue 5, November 2014, Pages: 326–341, P. Lepping, C. Schönfeldt-Lecuona, R. S. Sambhi, S. V. N. Lanka, S. Lane, R. Whittington, S. Leucht and R. Poole

    Version of Record online : 11 APR 2014, DOI: 10.1111/acps.12276

  3. You have full text access to this OnlineOpen article
    Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials

    British Journal of Clinical Pharmacology

    Volume 63, Issue 5, May 2007, Pages: 595–613, Roberto Gomeni and Emilio Merlo-Pich

    Version of Record online : 15 NOV 2006, DOI: 10.1111/j.1365-2125.2006.02815.x

  4. Gepirone-ER Treatment of Low Sexual Desire Associated with Depression in Women as Measured by the DeRogatis Inventory of Sexual Function (DISF) Fantasy/Cognition (Desire) Domain—A Post Hoc Analysis

    The Journal of Sexual Medicine

    Volume 8, Issue 9, September 2011, Pages: 2569–2581, Louis F. Fabre, Louis C. Smith and Leonard R. DeRogatis

    Version of Record online : 27 JUN 2011, DOI: 10.1111/j.1743-6109.2011.02330.x

  5. A New Population-Enrichment Strategy to Improve Efficiency of Placebo-Controlled Clinical Trials of Antidepressant Drugs

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 5, November 2010, Pages: 634–642, E Merlo-Pich, R C Alexander, M Fava and R Gomeni

    Version of Record online : 22 SEP 2010, DOI: 10.1038/clpt.2010.159

  6. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  7. You have free access to this content
    Why Has the Antidepressant–Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades?

    CNS Neuroscience & Therapeutics

    Volume 16, Issue 4, August 2010, Pages: 217–226, Arif Khan, Amritha Bhat, Russell Kolts, Michael E. Thase and Walter Brown

    Version of Record online : 16 APR 2010, DOI: 10.1111/j.1755-5949.2010.00151.x

  8. St John's wort for major depression

    Intervention Review

    The Cochrane Library

    Klaus Linde, Michael M Berner and Levente Kriston

    Published Online : 8 OCT 2008, DOI: 10.1002/14651858.CD000448.pub3

  9. Model-Based Approach and Signal Detection Theory to Evaluate the Performance of Recruitment Centers in Clinical Trials With Antidepressant Drugs

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 3, September 2008, Pages: 378–384, E Merlo-Pich and R Gomeni

    Version of Record online : 30 APR 2008, DOI: 10.1038/clpt.2008.70

  10. Does Pain Interfere with Antidepressant Depression Treatment Response and Remission in Patients with Depression and Pain? An Evidence-Based Structured Review

    Pain Medicine

    Volume 15, Issue 9, September 2014, Pages: 1522–1539, David A. Fishbain, Brandly Cole, John E. Lewis and Jinrun Gao

    Version of Record online : 19 AUG 2014, DOI: 10.1111/pme.12448

  11. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression

    International Journal of Clinical Practice

    Volume 61, Issue 8, August 2007, Pages: 1337–1348, R. C. Shelton, A. Prakash, C. H. Mallinckrodt, M. M. Wohlreich, J. Raskin, M. J. Robinson and M. J. Detke

    Version of Record online : 10 JUL 2007, DOI: 10.1111/j.1742-1241.2007.01444.x

  12. Non-remission of depression in the general population as assessed by the HAMD-7 scale

    Depression and Anxiety

    Volume 25, Issue 5, 1 May 2008, Pages: 393–397, Andrew G. Bulloch and Scott B. Patten

    Version of Record online : 18 OCT 2007, DOI: 10.1002/da.20396

  13. Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol

    Human Psychopharmacology: Clinical and Experimental

    Volume 27, Issue 1, January 2012, Pages: 47–56, Tina Marie Myers Oakes, Adam L. Myers, Lauren B. Marangell, Jonna Ahl, Apurva Prakash, Michael E. Thase and Susan G. Kornstein

    Version of Record online : 13 JAN 2012, DOI: 10.1002/hup.1262

  14. You have free access to this content
    Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder

    Psychiatry and Clinical Neurosciences

    Volume 66, Issue 1, February 2012, Pages: 8–16, Ching-I Hung, Chia-Yih Liu, Ching-Hui Yang and Shuu-Jiun Wang

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1440-1819.2011.02286.x

  15. Persistent benefits of slow titration of paroxetine in a six-month follow-up

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 5, September 2015, Pages: 329–333, Paolo Olgiati and Alessandro Serretti

    Version of Record online : 21 APR 2015, DOI: 10.1002/hup.2478

  16. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study

    Human Psychopharmacology: Clinical and Experimental

    Volume 18, Issue 2, March 2003, Pages: 113–119, Joseph Zohar, Harman Keegstra and Lucien Barrelet

    Version of Record online : 30 JAN 2003, DOI: 10.1002/hup.442

  17. Comparative analysis of observer depression scales

    Acta Psychiatrica Scandinavica

    Volume 72, Issue 3, September 1985, Pages: 239–245, W. Maier and M. Philipp

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1985.tb02601.x

  18. Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 2, March 2013, Pages: 151–159, Dan J Stein, Francoise Picarel-Blanchot and Sidney H Kennedy

    Version of Record online : 27 MAR 2013, DOI: 10.1002/hup.2294

  19. The validity of the Hamilton and Montgomery-Åsberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease

    International Journal of Geriatric Psychiatry

    Volume 15, Issue 7, July 2000, Pages: 644–649, Albert F. G. Leentjens, Frans R. J. Verhey, Richel Lousberg, Harro Spitsbergen and Frederik W. Wilmink

    Version of Record online : 26 JUL 2000, DOI: 10.1002/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L

  20. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression

    Acta Psychiatrica Scandinavica

    Volume 96, Issue 6, December 1997, Pages: 497–504, E. Leinonen, U. Lepola, H. Koponen, O.-P. Mehtonen and R. Rimon

    Version of Record online : 13 NOV 2007, DOI: 10.1111/j.1600-0447.1997.tb09953.x